Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population

NCT03962881 is registered in ClinicalTrials.gov with Shanxi Medical University as lead sponsor.

NCT NCT03962881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03962881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population
Lead sponsor
Shanxi Medical University
Phase
Phase 4
Overall status
Unknown status
Start date
May 25, 2019
Completion date
December 31, 2023
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b vaccine